We are live on ! Find out more
DA

DSC Advisors Portfolio holdings

AUM $11M
1-Year Est. Return 5.88%
This Fund
S&P 500
This Quarter Est. Return
+10.53%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$165M
AUM Growth
+$5.63M
Cap. Flow
-$205M
Cap. Flow %
-124.57%
Top 10 Hldgs %
61.25%
Holding
76
New
17
Increased
13
Reduced
26
Closed
10

Sector Composition

1 Healthcare 54.24%
2 Financials 15.26%
3 Communication Services 6.3%
4 Materials 6.15%
5 Technology 5.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FOMX
1
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$15.4M 9.38%
1,667,377
+169,166
+11% +$1.41M
CAH icon
2
Cardinal Health
CAH
$53.6B
$14M 8.51%
180,220
-17
-0% -$1.37K
CVS icon
3
CVS Health
CVS
$136B
$13.5M 8.21%
151,909
-95
-0.1% -$8.97K
JPM icon
4
JPMorgan Chase
JPM
$912B
$10.5M 6.39%
157,934
-17
-0% -$1.11K
BERY
5
DELISTED
Berry Global Group, Inc.
BERY
$10.1M 6.13%
250,470
NSTG
6
DELISTED
NanoString Technologies, Inc.
NSTG
$9.29M 5.65%
465,000
GS icon
7
Goldman Sachs
GS
$323B
$8.9M 5.41%
55,177
-35
-0.1% -$5.69K
HCA icon
8
HCA Healthcare
HCA
$85.6B
$7.99M 4.85%
105,631
-184
-0.2% -$14.1K
ELV icon
9
Elevance Health
ELV
$80.9B
$5.7M 3.46%
45,496
-144
-0.3% -$18.6K
APTV icon
10
Aptiv
APTV
$12.5B
$5.35M 3.25%
75,000
AET
11
DELISTED
Aetna Inc
AET
$5.21M 3.17%
45,163
+34,307
+316% +$4.02M
NEOS
12
DELISTED
Neos Therapeutics, Inc
NEOS
$5.16M 3.14%
784,704
+91,122
+13% +$722K
PARA
13
DELISTED
Paramount Global Class B
PARA
$4.65M 2.83%
85,000
PFNX
14
DELISTED
Pfenex Inc.
PFNX
$4.57M 2.77%
510,000
+10,000
+2% +$85.3K
BIIB icon
15
Biogen
BIIB
$30.8B
$4.41M 2.68%
14,078
-6
-0% -$1.78K
ZVRA icon
16
Zevra Therapeutics
ZVRA
$754M
$4.24M 2.57%
58,968
SPY icon
17
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$4.13M 2.51%
1,659,300
-1,026,900
-38% -$222M
TEL icon
18
TE Connectivity
TEL
$59.1B
$4.06M 2.46%
63,000
TWX
19
DELISTED
Time Warner Inc
TWX
$3.02M 1.83%
37,926
-25
-0.1% -$1.95K
AMGN icon
20
Amgen
AMGN
$201B
$2.56M 1.55%
15,331
+18
+0.1% +$3.04K
IWO icon
21
iShares Russell 2000 Growth ETF
IWO
$14.7B
$2.11M 1.28%
+14,160
New +$2.06M
DVAX
22
DELISTED
Dynavax Technologies
DVAX
$1.63M 0.99%
155,000
HRI icon
23
Herc Holdings
HRI
$5.11B
$1.56M 0.95%
+46,259
New +$1.55M
TIP icon
24
iShares TIPS Bond ETF
TIP
$14.5B
$1.45M 0.88%
12,420
-1,200
-9% -$139K
IWN icon
25
iShares Russell 2000 Value ETF
IWN
$14.4B
$1.23M 0.75%
+11,760
New +$1.21M

Similar funds

DSC Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, DSC Advisors held 76 positions worth $165M, up 3.5% from $159M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

DSC Advisors withdrew a net $205M in Q3 2016, closing 10 positions and reducing 26 holdings. Its most notable exit was Swift Transportation Company, an estimated $4.91M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, up from 51% a quarter earlier, followed by Financials and Communication Services.

Against the trend, DSC Advisors opened a new position in iShares Russell 2000 Growth ETF worth $2.11M.

  • DSC Advisors's largest Q3 2016 buy was iShares Russell 2000 Growth ETF: 14,160 shares worth $2.11M.
  • DSC Advisors added most to Aetna Inc in Q3 2016, an estimated $4.02M increase.
  • DSC Advisors's biggest Q3 2016 reduction was Microsoft, cutting an estimated $1.53M.
  • DSC Advisors fully exited Swift Transportation Company in Q3 2016, selling an estimated $4.91M.
  • DSC Advisors's ten largest holdings make up 61% of its $165M portfolio in Q3 2016.
  • DSC Advisors opened 17 new positions and closed 10 in Q3 2016.
  • DSC Advisors's portfolio value rose 3.5% quarter-over-quarter to $165M.

Based on DSC Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.